Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2026-06-19 @ 8:39 PM
Study NCT ID:
NCT01107535
Status:
COMPLETED
Last Update Posted:
2012-10-31
First Post:
2010-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection
Sponsor:
Abbott
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PMOS-PERU 07-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None